News and Insights

Medical Device and Diagnostics

It’s Time for Pharma to Reimagine a New Role for Medical Affairs

Pharmaceutical Executive

Among the many trends accelerated by the pandemic was the overhaul of pharma’s commercial model. It was tacitly understood to be ripe for change – the cost was increasingly conspicuous, and the results increasingly suspect. The prior model had grown out of step with field realities. Employed physicians had less…

The Future of Medical Affairs: Impact of the Evolving Healthcare Landscape

The pandemic has dramatically accelerated many changes across healthcare, and one of them is redefinition of Medical Affairs’ role in commercialization. The shift to virtual detailing and the increased focus on economic and clinical value have implications for Medical Affairs well beyond staffing numbers. These changes demand that Medical Affairs…

The Impact of Covid-19 on Manufacturers’ Commercial Model

In response to Covid-19, manufacturers have quickly adapted their commercial approaches. But which of those changes are permanent? What additional capabilities do organizations need to succeed in the “new normal”? What has Covid-19 shown us about weaknesses in the traditional commercial model? To understand the extent to which the pandemic…

The Numerof 2021 Global Medical Device Outlook

Infographic

As our Numerof 2021 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about continuing to adapt to pressures on price and demands for value. You’ll continue to engage in new and different ways with healthcare delivery, physicians, regulators, public and private payers, consumers,…